Skip to main content

Singular Genomics Systems, Inc.

OMICDelisted Feb 21, 2025
Industry
Laboratory Analytical Instruments
SEC CIK
0001850906

Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Singular Genomics Systems, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of OMIC: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders7674−2
Shares39.0M40.2M+1.19M (+3.1%)
Value$149.1M$100.5M−$48.5M (−32.5%)

New holders (12)

Institutions that held Singular Genomics Systems, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to OMIC in Q3 2022
InstitutionSharesValue% of portfolio
Keybank National Association353,815$885.0K0.00%
Gsa Capital Partners LLP40,669$102.0K0.01%
Virtu Financial LLC13,251$33.0K0.00%
Balyasny Asset Management LLC10,511$26.0K0.00%
EP Wealth Advisors, LLC10,576$26.0K0.00%
Simplex Trading, LLC942$2.00K0.00%
China Universal Asset Management Co., Ltd.667$2.00K0.00%
Advisor Group Holdings, Inc.260$1.00K0.00%
Parallel Advisors, LLC322$1.00K0.00%
Capital Advisors, Ltd. LLC168$00.00%
State of Wyoming38$00.00%
Ronald Blue Trust, Inc.67$00.00%

Sold out (14)

Institutions that held Singular Genomics Systems, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.